首页> 中文期刊> 《中国实用医药》 >气管镜下给药治疗重症肺炎患者的临床效果观察

气管镜下给药治疗重症肺炎患者的临床效果观察

         

摘要

Objective To explore the clinical effect of drug treatment under bronchoscope for patients with severe pneumonia. Methods A total of 60 patients with severe pneumonia were divided by complete sampling survey method for 1∶1 into observation group and control group, and each group contained 30 cases. The observation group received drug treatment under bronchoscope, and the control group received conventional treatment. The clinical effects of the two groups were compared. Results After the treatment, both groups had improved breathing mechanics indexes. The observation group had much obvious improvement in inflammatory cytokines than the control group, and the difference had statistical significance (P<0.05). Conclusion Drug treatment under bronchoscope can improve clinical signs of severe pneumonia, and its curative effect is precise.%目的:探究气管镜下给药治疗重症肺炎患者的临床效果。方法60例重症肺炎患者,按照完全抽样调查法1∶1分成观察组和对照组,每组30例;观察组行气管镜下给药治疗,对照组行常规治疗,分析比较两组的临床疗效。结果治疗后,两组患者呼吸力学的各项检测指标均有所改善,且观察组炎性细胞因子较对照组有明显改善,差异有统计学意义(P<0.05)。结论气管镜下给药治疗重症肺炎可改善患者的临床体征,治疗效果显著。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号